• Explore /
  • Poster
  • / Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) pts receiving a new agent (NA)-based third line treatment: Preliminary results from a multicenter Italian study.

Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) pts receiving a new agent (NA)-based third line treatment: Preliminary results from a multicenter Italian study.

Abstract Poster

Authors

null

Orazio Caffo

Santa Chiara Hospital, Trento, Italy

Orazio Caffo , Ugo De Giorgi , Daniele Alesini , Lucia Fratino , Cinzia Ortega , Marcello Tucci , Sarah Scagliarini , Vittorina Zagonel , Paolo Andrea Zucali , Franco Morelli , Donata Sartori , Roberto Sabbatini , Alessandro D'Angelo , Maddalena Donini , Sandro Barni , Giuseppe Procopio , Zuzana Sirotova , Teodoro Sava , Vincenza Conteduca , Enzo Galligioni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 211)

DOI

10.1200/jco.2016.34.2_suppl.211

Abstract #

211

Poster Bd #

J4

Abstract Disclosures

Similar Posters

First Author: Orazio Caffo

First Author: Celestia S. Higano

First Author: Orazio Caffo

First Author: Orazio Caffo